Compare NAUT & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAUT | HIX |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.5M | 376.5M |
| IPO Year | 2020 | 1998 |
| Metric | NAUT | HIX |
|---|---|---|
| Price | $2.64 | $3.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 296.9K | ★ 333.1K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | ★ 16.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $992.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $3.75 |
| 52 Week High | $4.31 | $4.39 |
| Indicator | NAUT | HIX |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 48.08 |
| Support Level | $1.82 | $3.88 |
| Resistance Level | $3.18 | $4.26 |
| Average True Range (ATR) | 0.24 | 0.05 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 11.56 | 31.20 |
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.